FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004287235> ?p ?o ?g. }

• W2004287235 endingPage "1245" @default.
• W2004287235 startingPage "1237" @default.
• W2004287235 abstract "Article AbstractObjective: The therapeutics for bipolar disorders are still far from adequate, and new options with improved effectiveness, safety, and tolerability in a wide range of patients are necessary. Preliminary data have suggested a role for dysfunctions targeting the purinergic system in mood disorders. This study aimed to evaluate the efficacy and tolerability of the purinergic agents allopurinol and dipyridamole combined with lithium in bipolar mania. Method: A randomized, placebo-controlled, double-blind study was performed in adult inpatients (N = 180) with a DSM-IV-TR diagnosis of bipolar I disorder, current episode manic with or without psychotic features (rapid cyclers and mixed episodes were not included). No antipsychotic agent was used during the study. Subjects were given fixed oral doses of either allopurinol 600 mg/day (N =60), dipyridamole 200 mg/day (N = 60), or placebo (N = 60) added to lithium for 4 weeks. Subjects were rated at baseline and days 7, 14, 21, and 28 using the Young Mania Rating Scale (YMRS) as the primary efficacy measure. The study was conducted between September 2003 and September 2006. Results: Allopurinol resulted in greater mean reductions in YMRS scores from baseline to day 21 (p < .001) and day 28 (p = .003) compared with placebo using a linear model analysis (d = 0.32, 95% CI = 0.07 to 0.57). Remission rates were significantly higher for allopurinol compared with dipyridamole and placebo (p = .008). Lithium showed a significant antimanic efficacy even in the placebo group. Decrease in plasma uric acid levels showed a significant positive association with antimanic effects in the allopurinol group (p < .001). Conclusion: Allopurinol is clinically effective and well-tolerated adjunctively with lithium in manic episodes and may represent an alternative approach in the treatment of acute mania, especially for those presenting tolerability and safety issues with antipsychotics. The present results strongly support the involvement of the purinergic system in the pathophysiology and therapeutics of bipolar disorder. Further placebo-controlled studies with allopurinol compared with standard mood stabilizers in mania and maintenance are warranted.Trial Registration: clinicaltrials.gov Identifier: NCT00560079" @default.
• W2004287235 created "2016-06-24" @default.
• W2004287235 creator A5009988293 @default.
• W2004287235 creator A5029769926 @default.
• W2004287235 creator A5053545982 @default.
• W2004287235 creator A5066511141 @default.
• W2004287235 creator A5078397819 @default.
• W2004287235 creator A5082192669 @default.
• W2004287235 creator A5086133175 @default.
• W2004287235 creator A5088021168 @default.
• W2004287235 creator A5088825358 @default.
• W2004287235 creator A5090656363 @default.
• W2004287235 date "2008-08-15" @default.
• W2004287235 modified "2023-09-26" @default.
• W2004287235 title "A Double-Blind, Randomized, Placebo-Controlled 4-Week Study on the Efficacy and Safety of the Purinergic Agents Allopurinol and Dipyridamole Adjunctive to Lithium in Acute Bipolar Mania" @default.
• W2004287235 cites W1576503935 @default.
• W2004287235 cites W1960792000 @default.
• W2004287235 cites W1963941498 @default.
• W2004287235 cites W1994999924 @default.
• W2004287235 cites W2000101136 @default.
• W2004287235 cites W2008515973 @default.
• W2004287235 cites W2010596549 @default.
• W2004287235 cites W2032372559 @default.
• W2004287235 cites W2036089822 @default.
• W2004287235 cites W2042902270 @default.
• W2004287235 cites W2044284130 @default.
• W2004287235 cites W2047511549 @default.
• W2004287235 cites W2060883428 @default.
• W2004287235 cites W2073582213 @default.
• W2004287235 cites W2076444692 @default.
• W2004287235 cites W2091751785 @default.
• W2004287235 cites W2100231049 @default.
• W2004287235 cites W2118005924 @default.
• W2004287235 cites W2119515450 @default.
• W2004287235 cites W2120608834 @default.
• W2004287235 cites W2124038655 @default.
• W2004287235 cites W2143438415 @default.
• W2004287235 cites W2167659819 @default.
• W2004287235 cites W2169118055 @default.
• W2004287235 cites W2172099127 @default.
• W2004287235 cites W2173671065 @default.
• W2004287235 cites W2265946675 @default.
• W2004287235 cites W2328872480 @default.
• W2004287235 cites W2340882247 @default.
• W2004287235 cites W2409656836 @default.
• W2004287235 cites W36353745 @default.
• W2004287235 doi "https://doi.org/10.4088/jcp.v69n0806" @default.
• W2004287235 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2727594" @default.
• W2004287235 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18681754" @default.
• W2004287235 hasPublicationYear "2008" @default.
• W2004287235 type Work @default.
• W2004287235 sameAs 2004287235 @default.
• W2004287235 citedByCount "112" @default.
• W2004287235 countsByYear W20042872352012 @default.
• W2004287235 countsByYear W20042872352013 @default.
• W2004287235 countsByYear W20042872352014 @default.
• W2004287235 countsByYear W20042872352015 @default.
• W2004287235 countsByYear W20042872352016 @default.
• W2004287235 countsByYear W20042872352017 @default.
• W2004287235 countsByYear W20042872352018 @default.
• W2004287235 countsByYear W20042872352019 @default.
• W2004287235 countsByYear W20042872352020 @default.
• W2004287235 countsByYear W20042872352021 @default.
• W2004287235 countsByYear W20042872352022 @default.
• W2004287235 countsByYear W20042872352023 @default.
• W2004287235 crossrefType "journal-article" @default.
• W2004287235 hasAuthorship W2004287235A5009988293 @default.
• W2004287235 hasAuthorship W2004287235A5029769926 @default.
• W2004287235 hasAuthorship W2004287235A5053545982 @default.
• W2004287235 hasAuthorship W2004287235A5066511141 @default.
• W2004287235 hasAuthorship W2004287235A5078397819 @default.
• W2004287235 hasAuthorship W2004287235A5082192669 @default.
• W2004287235 hasAuthorship W2004287235A5086133175 @default.
• W2004287235 hasAuthorship W2004287235A5088021168 @default.
• W2004287235 hasAuthorship W2004287235A5088825358 @default.
• W2004287235 hasAuthorship W2004287235A5090656363 @default.
• W2004287235 hasBestOaLocation W20042872352 @default.
• W2004287235 hasConcept C118552586 @default.
• W2004287235 hasConcept C126322002 @default.
• W2004287235 hasConcept C142724271 @default.
• W2004287235 hasConcept C15744967 @default.
• W2004287235 hasConcept C197934379 @default.
• W2004287235 hasConcept C202061045 @default.
• W2004287235 hasConcept C204787440 @default.
• W2004287235 hasConcept C27081682 @default.
• W2004287235 hasConcept C2776174506 @default.
• W2004287235 hasConcept C2776412080 @default.
• W2004287235 hasConcept C2776809841 @default.
• W2004287235 hasConcept C2776921671 @default.
• W2004287235 hasConcept C2777089681 @default.
• W2004287235 hasConcept C2778375690 @default.
• W2004287235 hasConcept C2778541603 @default.
• W2004287235 hasConcept C2780494398 @default.
• W2004287235 hasConcept C2780550438 @default.
• W2004287235 hasConcept C2991744798 @default.
• W2004287235 hasConcept C42219234 @default.
• W2004287235 hasConcept C71924100 @default.
• W2004287235 hasConceptScore W2004287235C118552586 @default.

• next